Sign in
4

Changes in Ownership

SpyGlass Pharma, Inc. Filed Acc 0001193125-26-045029

Director bought 165,000 shares at $16.00 ($2,640,000)

  • Director acquired 3,145,619 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nielsen Kirk G. Director 2026-02-09 Conversion +1,690,230 1,690,230 I: show line 1 in the form
Nielsen Kirk G. Director 2026-02-09 Conversion +548,067 2,238,297 I: show line 2 in the form
Nielsen Kirk G. Director 2026-02-09 Conversion +548,067 2,786,364 I: show line 3 in the form
Nielsen Kirk G. Director 2026-02-09 Conversion +359,255 3,145,619 I: show line 4 in the form
Nielsen Kirk G. Director 2026-02-09 Purchase +165,000 $16.00 $2,640,000 3,310,619 I: show line 5 in the form
Open-market purchases · 165,000 sh · avg $16.00 · $2,640,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Nielsen Kirk G. Director 2026-02-09 Conversion · Series B Preferred Stock −9,689,922 0 I: show line 6 in the form
Nielsen Kirk G. Director 2026-02-09 Conversion · Series C-1 Preferred Stock −3,142,015 0 I: show line 7 in the form
Nielsen Kirk G. Director 2026-02-09 Conversion · Series C-2 Preferred Stock −3,142,015 0 I: show line 8 in the form
Nielsen Kirk G. Director 2026-02-09 Conversion · Series D Preferred Stock −2,059,573 0 I: show line 9 in the form
Loading xslF345X05/ownership.xml…